Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-53,075
Closed -$2.03M 390
2021
Q2
$2.03M Hold
53,075
0.1% 133
2021
Q1
$1.41M Sell
53,075
-1,429
-3% -$43.5K 0.08% 139
2020
Q4
$1.74M Hold
54,504
0.11% 111
2020
Q3
$1.21M Buy
54,504
+6,696
+14% +$153K 0.09% 107
2020
Q2
$1.13M Hold
47,808
0.09% 109
2020
Q1
$755K Buy
47,808
+893
+2% +$25.1K 0.07% 119
2019
Q4
$1.47M Hold
46,915
0.11% 104
2019
Q3
$1.23M Buy
46,915
+10,993
+31% +$259K 0.11% 109
2019
Q2
$932K Buy
35,922
+2,324
+7% +$81K 0.08% 115
2019
Q1
$1.27M Buy
33,598
+6,062
+22% +$277K 0.12% 103
2018
Q4
$1.15M Buy
27,536
+3,777
+16% +$156K 0.12% 102
2018
Q3
$1.01M Sell
23,759
-1,875
-7% -$99K 0.11% 114
2018
Q2
$1.32M Buy
+25,634
New +$1.41M 0.15% 99

Other funds holding NTNX

GW & Wade's NTNX Position: Q3 2021 in Review

GW & Wade sold out of Nutanix (NTNX) in Q3 2021, closing a stake of 53,075 shares — an estimated $2.03M sold.

GW & Wade first reported a position in NTNX in Q2 2018 and held it in 13 quarters. The position peaked at $2.03M in Q2 2021. 322 funds tracked by Wall St. Rank hold NTNX as of Q3 2021.

  • GW & Wade reported no remaining Nutanix position as of Q3 2021 after selling out during the quarter.
  • GW & Wade sold 53,075 Nutanix shares in Q3 2021, an estimated $2.03M.
  • GW & Wade first reported a position in Nutanix in Q2 2018 and held it in 13 quarters.
  • GW & Wade's Nutanix position peaked at $2.03M in Q2 2021.
  • 322 funds tracked by Wall St. Rank held Nutanix as of Q3 2021.

Based on GW & Wade's 13F filing for Q3 2021, filed 3 Nov 2021.